Clinical observation on the treatment of breast cancer with traditional Chinese and western medicine
10.3760/cma.j.issn.1673-4246.2012.07.010
- VernacularTitle:生血汤加减联合放疗对乳腺癌患者外周血癌胚抗原、基质金属蛋白酶-2、金属蛋白酶抑制剂-2的影响
- Author:
Fuqiang JIANG
;
Jing LI
- Publication Type:Journal Article
- Keywords:
Breast cancer;
Shengxue decoction;
MMP-2;
TIMP-2
- From:International Journal of Traditional Chinese Medicine
2012;34(7):610-612
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the influence of breast cancer treated with chemo-therapy and Shengxue decoction.Methods 91 Cases of breast cancer were randomly recurited into two groups:The western medicine treatment group (40 patients) was given anastrozole tablets and chemo-therapy; The Chinese and western medicine treatment group (51 patients) was given chemo-therapy and Shengxue decoction.Results The total effective rate of was 82％ and 53％ in the Chinese and western medicine treatment group and western medicine treatment group respectively,the difference was statistically significant (x2=19.74,P＜0.05).The peripheral blood's CEA and MMP-2 mRNA expression of western medicine treatment were [ (7.50 ±4.32)ng/ml、(116.32±67.40)ng/ml respectively],higher than the Chinese and western medicine treatment group [ (7.20 ± 3.22) ng/ml、(105.08 ± 37.82) ng/ml,respectively,P＜ 0.05 ],but the TIMP-2/MMP-2 (26.65 ±19.75) was significantly lower compared with the Chinese and western medicine treatment group [ (39.48±21.21) (P＜0.05) ].Conclusion The combination of traditional Chinese and western medicine was effective in treatment of breast cancer and well worth for popularization.
